Targeting protein kinases for cancer therapy
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Hoboken, N.J.
Wiley
c2010
|
Schlagworte: | |
Online-Zugang: | DE-91 Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV040472844 | ||
003 | DE-604 | ||
005 | 20130325 | ||
007 | cr|uuu---uuuuu | ||
008 | 121011s2010 xx o|||| 00||| eng d | ||
020 | |a 0470555289 |c electronic bk. |9 0-470-55528-9 | ||
020 | |a 0470555297 |c electronic bk. |9 0-470-55529-7 | ||
020 | |a 9780470555286 |c electronic bk. |9 978-0-470-55528-6 | ||
020 | |a 9780470555293 |c electronic bk. |9 978-0-470-55529-3 | ||
035 | |a (OCoLC)699597274 | ||
035 | |a (DE-599)BVBBV040472844 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-91 | ||
100 | 1 | |a Matthews, David J. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Targeting protein kinases for cancer therapy |c David J. Matthews, Mary E. Gerritsen |
264 | 1 | |a Hoboken, N.J. |b Wiley |c c2010 | |
300 | |a 1 Online-Ressource (xiii, 702 p.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a An expert guide to targeting protein kinases in cancer therapy. Research has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharma-ceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication. Complete with full-color presentations, Targeting Protein Kinases for Cancer Therapydefines the structural features of protein kinases and examines their cellular functions. | ||
650 | 4 | |a Protein kinases / Inhibitors / Therapeutic use | |
650 | 4 | |a Antineoplastic agents | |
650 | 4 | |a Protein kinases | |
650 | 4 | |a Neoplasms / drug therapy | |
650 | 4 | |a Protein Kinase Inhibitors / therapeutic use | |
650 | 4 | |a Drug Discovery | |
650 | 4 | |a Drug Resistance, Neoplasm | |
650 | 4 | |a Protein Kinases / physiology | |
650 | 4 | |a Protein-Tyrosine Kinases / antagonists & inhibitors | |
650 | 0 | 7 | |a Proteinkinasen |0 (DE-588)4175996-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | 2 | |a Proteinkinasen |0 (DE-588)4175996-5 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Gerritsen, Mary E. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-22965-9 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-22965-1 |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 |x Verlag |3 Volltext |
912 | |a ZDB-4-NLEBK | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-025320133 | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 |l DE-91 |p ZDB-4-NLEBK |q TUM_PDA_EBSCO_MED_gekauft |x Verlag |3 Volltext |
Datensatz im Suchindex
DE-BY-TUM_katkey | 1882065 |
---|---|
_version_ | 1820881329243291648 |
any_adam_object | |
author | Matthews, David J. |
author_facet | Matthews, David J. |
author_role | aut |
author_sort | Matthews, David J. |
author_variant | d j m dj djm |
building | Verbundindex |
bvnumber | BV040472844 |
collection | ZDB-4-NLEBK |
ctrlnum | (OCoLC)699597274 (DE-599)BVBBV040472844 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03013nam a2200589zc 4500</leader><controlfield tag="001">BV040472844</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130325 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">121011s2010 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470555289</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-55528-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470555297</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-55529-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470555286</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-55528-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470555293</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-55529-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)699597274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040472844</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Matthews, David J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeting protein kinases for cancer therapy</subfield><subfield code="c">David J. Matthews, Mary E. Gerritsen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">Wiley</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 702 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">An expert guide to targeting protein kinases in cancer therapy. Research has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharma-ceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication. Complete with full-color presentations, Targeting Protein Kinases for Cancer Therapydefines the structural features of protein kinases and examines their cellular functions.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein kinases / Inhibitors / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein kinases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein Kinase Inhibitors / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Neoplasm</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein Kinases / physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein-Tyrosine Kinases / antagonists & inhibitors</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteinkinasen</subfield><subfield code="0">(DE-588)4175996-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Proteinkinasen</subfield><subfield code="0">(DE-588)4175996-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerritsen, Mary E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-22965-9</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-22965-1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025320133</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCO_MED_gekauft</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV040472844 |
illustrated | Not Illustrated |
indexdate | 2024-12-24T02:51:02Z |
institution | BVB |
isbn | 0470555289 0470555297 9780470555286 9780470555293 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025320133 |
oclc_num | 699597274 |
open_access_boolean | |
owner | DE-91 DE-BY-TUM |
owner_facet | DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (xiii, 702 p.) |
psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCO_MED_gekauft |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Wiley |
record_format | marc |
spellingShingle | Matthews, David J. Targeting protein kinases for cancer therapy Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen (DE-588)4175996-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Therapie (DE-588)4059798-2 gnd |
subject_GND | (DE-588)4175996-5 (DE-588)4073781-0 (DE-588)4059798-2 |
title | Targeting protein kinases for cancer therapy |
title_auth | Targeting protein kinases for cancer therapy |
title_exact_search | Targeting protein kinases for cancer therapy |
title_full | Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen |
title_fullStr | Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen |
title_full_unstemmed | Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen |
title_short | Targeting protein kinases for cancer therapy |
title_sort | targeting protein kinases for cancer therapy |
topic | Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen (DE-588)4175996-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Therapie (DE-588)4059798-2 gnd |
topic_facet | Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen Krebs Medizin Therapie |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 |
work_keys_str_mv | AT matthewsdavidj targetingproteinkinasesforcancertherapy AT gerritsenmarye targetingproteinkinasesforcancertherapy |